Sort
261,768 grants matching “gene therapy”
Mechanisms of fibrosis in post-surgical lymphedema
$858,115Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2018 · HL
Structural Analysis of Biological Membrane Proteins
$858,091Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
A Role for the Novel HAF-NFkappaB Axis in Driving Obesity-Associated Liver Cancer
$858,089Mei Yee Koh · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Cancer Immunotherapy Clinical Trials
$858,075Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence
$858,030Robert D. Burk · Albert Einstein College Of Medicine · R01 · FY2022 · DE
Assessment, Therapy and Prevention Of Autoimmune Disease
$858,012Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
$857,882Shalendar Bhasin · Brigham And Women'S Hospital · U01 · FY2024 · AG
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap
$857,774Leyla S Diaz · Functional Genetics, Inc. · R44 · FY2010 · AI
NEI Genetic Engineering Core
$857,725Lijin Dong · National Eye Institute · ZIC · FY2012 · EY
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
$857,707James Even Voss · Scripps Research Institute, The · R01 · FY2025 · AI
Tissue chips for precision treatment of catecholaminergic polymorphic ventricular tachycardia
$857,694William T Pu · Boston Children'S Hospital · UH3 · FY2022 · TR
Investigation of sex variation in PD-1/pSTAT3/IL-17A signaling in sarcoidosis pathogenesis
$857,679Wonder P. Drake · Vanderbilt University Medical Center · R56 · FY2020 · HL
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort
$857,594Howard D Strickler · Albert Einstein College Of Medicine · R01 · FY2011 · CA
Disparities in Breast Cancer: Development and Survival in Hispanic and NHW Women
$857,565Martha Or Marty L Slattery · University Of Utah · R01 · FY2010 · CA
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease
$857,555Thomas Dick · Hackensack University Medical Center · R01 · FY2023 · AI
Basic and Translational Research iPSC-based hematologic and vascular therapies
$857,523John P Cooke · Methodist Hospital Research Institute · U01 · FY2014 · HL
Immune interventions in SIV-infected ART-suppressed infant macaques
$857,514Ann M Chahroudi · Emory University · R01 · FY2017 · AI
Reducing Latent Viral Reservoirs in Infant Macaques
$857,506Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2022 · HD
Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations
$857,429Anne M Connolly · Research Inst Nationwide Children'S Hosp · U01 · FY2025 · NS
Pain Mechanisms in Fabry Disease
$857,423Cheryl Louise Stucky · Medical College Of Wisconsin · R37 · FY2025 · NS
Pain Mechanisms in Fabry Disease
$857,423Cheryl Louise Stucky · Medical College Of Wisconsin · R37 · FY2023 · NS
Comparative Medicine Shared Resource
$857,373Gordon Roble · Fred Hutchinson Cancer Center · P30 · FY2025 · CA
Cell-free assay technologies for the identification of active compounds
$857,347Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Development and Validation of Animal Models and/or Outcome Measures
$857,308Joshua J.c. Rosenthal · Marine Biological Laboratory · U19 · FY2021 · NS
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
$857,294William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2016 · HL